Drug Shortage Report for LOVENOX
| Report ID | 145975 |
| Drug Identification Number | 02378442 |
| Brand name | LOVENOX |
| Common or Proper name | Lovenox 100mg |
| Company Name | SANOFI-AVENTIS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ENOXAPARIN SODIUM |
| Strength(s) | 100MG |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
| Packaging size | 10 |
| ATC code | B01AB |
| ATC description | ANTITHROMBOTIC AGENTS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2022-02-15 |
| Actual start date | |
| Estimated end date | 2022-03-24 |
| Actual end date | 2021-12-02 |
| Shortage status | Avoided shortage |
| Updated date | 2021-12-02 |
| Company comments | Transportation delay and overselling is leading to a limited supply of product. Allocation will be kept in place to mitigate the anticipated shortage. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2021-12-02 | French | Compare |
| v5 | 2021-12-02 | English | Compare |
| v4 | 2021-11-10 | French | Compare |
| v3 | 2021-11-10 | English | Compare |
| v2 | 2021-09-21 | French | Compare |
| v1 | 2021-09-21 | English | Compare |
Showing 1 to 6 of 6